Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women


Iversen O., Miranda M. J. , Ulied A., Soerdal T., Lazarus E., Chokephaibulkit K., ...More

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol.316, no.22, pp.2411-2421, 2016 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 316 Issue: 22
  • Publication Date: 2016
  • Doi Number: 10.1001/jama.2016.17615
  • Journal Name: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.2411-2421

Abstract

IMPORTANCE Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts.